Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Schlemmer

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Clinical Endocrinology|December 1, 1991
The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adultsA Schlemmer, J S Johansen, S A Pedersen, et al.
Bone|July 1, 1997
Circadian variation in bone resorption is not related to serum cortisolA Schlemmer, C Hassager, P Alexandersen, et al.
Scandinavian Journal of Rheumatology|June 21, 2021
Using a novel smartphone application for capturing of patient-reported outcome measures among patients with inflammatory arthritis:A randomized, crossover, agreement studyL Uhrenholt, R Christensen, L Dreyer, et al.
Scandinavian Journal of Rheumatology|February 6, 2023
Disease activity-guided tapering of biologics in patients with inflammatory arthritis: a pragmatic, randomized, open-label, equivalence trialL Uhrenholt, R Christensen, L Dreyer, et al.
Annals of the Rheumatic Diseases|October 23, 2015
Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction: a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA)K Hørslev-Petersen, M L Hetland, L M Ørnbjerg, et al.
The Pharmacogenomics Journal|May 6, 2015
Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritisS B Krintel, C Dehlendorff, M L Hetland, et al.
Scandinavian Journal of Rheumatology|July 10, 2018
Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trialC H Brahe, M Østergaard, J S Johansen, et al.
Clinical Rheumatology|December 7, 2016
Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trialL M Ørnbjerg, M Østergaard, T Jensen, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Clinical Endocrinology|December 1, 1991
The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adultsA Schlemmer, J S Johansen, S A Pedersen, et al.
Bone|July 1, 1997
Circadian variation in bone resorption is not related to serum cortisolA Schlemmer, C Hassager, P Alexandersen, et al.
Scandinavian Journal of Rheumatology|June 21, 2021
Using a novel smartphone application for capturing of patient-reported outcome measures among patients with inflammatory arthritis:A randomized, crossover, agreement studyL Uhrenholt, R Christensen, L Dreyer, et al.
Scandinavian Journal of Rheumatology|February 6, 2023
Disease activity-guided tapering of biologics in patients with inflammatory arthritis: a pragmatic, randomized, open-label, equivalence trialL Uhrenholt, R Christensen, L Dreyer, et al.
Annals of the Rheumatic Diseases|October 23, 2015
Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction: a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA)K Hørslev-Petersen, M L Hetland, L M Ørnbjerg, et al.
The Pharmacogenomics Journal|May 6, 2015
Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritisS B Krintel, C Dehlendorff, M L Hetland, et al.
Scandinavian Journal of Rheumatology|July 10, 2018
Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trialC H Brahe, M Østergaard, J S Johansen, et al.
Clinical Rheumatology|December 7, 2016
Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trialL M Ørnbjerg, M Østergaard, T Jensen, et al.
Pageof 3